529 related articles for article (PubMed ID: 19443365)
21. Breast cancer metastasis to bone: it is not all about PTHrP.
Bendre M; Gaddy D; Nicholas RW; Suva LJ
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S39-45. PubMed ID: 14600591
[TBL] [Abstract][Full Text] [Related]
22. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.
Chattopadhyay N
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E761-70. PubMed ID: 16603723
[TBL] [Abstract][Full Text] [Related]
23. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.
Altundag O; Altundag K; Selim Silay Y; Gunduz M; Demircan K; Gullu I
Med Hypotheses; 2004; 63(6):1010-3. PubMed ID: 15504568
[TBL] [Abstract][Full Text] [Related]
24. [Medical treatment of malignant hypercalcemia].
Eto S; Nakano Y; Okada Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonates and primary hyperparathyroidism.
Rodan GA
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793
[TBL] [Abstract][Full Text] [Related]
26. Hypercalcemia of cancer: an update.
Goni MH; Tolis G
Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538
[TBL] [Abstract][Full Text] [Related]
27. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
Reagan P; Pani A; Rosner MH
Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907
[TBL] [Abstract][Full Text] [Related]
28. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
Clines GA; Guise TA
Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of cancer-induced hypercalcemia.
Rosol TJ; Capen CC
Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
[TBL] [Abstract][Full Text] [Related]
31. Hypercalcemia of malignancy: pathophysiology and implications for treatment.
Theriault RL
Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542
[TBL] [Abstract][Full Text] [Related]
32. [Hypercalcemia in malignant diseases. Physiopathology and treatment].
Aasarød K; Lamvik J
Tidsskr Nor Laegeforen; 1989 Apr; 109(12):1293-6. PubMed ID: 2734758
[TBL] [Abstract][Full Text] [Related]
33. [Extraparathyroid hypercalcemias. Physiopathological and therapeutic aspects].
Houillier P; Blanchard A; Paillard M
Ann Med Interne (Paris); 1997; 148(1):15-8. PubMed ID: 9137694
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer bone metastasis and current small therapeutics.
Cicek M; Oursler MJ
Cancer Metastasis Rev; 2006 Dec; 25(4):635-44. PubMed ID: 17160709
[TBL] [Abstract][Full Text] [Related]
35. [How to treat tumor-induced hypercalcemia].
Body JJ
Rev Prat; 2003 Dec; 53(19):2128-35. PubMed ID: 15008469
[TBL] [Abstract][Full Text] [Related]
36. Hypercalcemia of malignancy: a review of advances in pathophysiology.
Kaplan M
Oncol Nurs Forum; 1994 Jul; 21(6):1039-46; quiz 1047-8. PubMed ID: 7971410
[TBL] [Abstract][Full Text] [Related]
37. [Hypercalcemia of malignancy: clinical features, diagnosis and treatment].
Farias ML
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):816-24. PubMed ID: 16444366
[TBL] [Abstract][Full Text] [Related]
38. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
Onuma E; Sato K; Saito H; Tsunenari T; Ishii K; Esaki K; Yabuta N; Wakahara Y; Yamada-Okabe H; Ogata E
Anticancer Res; 2004; 24(5A):2665-73. PubMed ID: 15517871
[TBL] [Abstract][Full Text] [Related]
39. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
40. Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy.
Ralston SH; Boyce BF; Cowan RA; Gardner MD; Fraser WD; Boyle IT
J Bone Miner Res; 1989 Feb; 4(1):103-11. PubMed ID: 2718773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
